Results: 1068

For: Treatment

Is third-wave CBT good value?

thought-catalog-674419-unsplash

Chris Sampson summarises a systematic review on the economic impact of third-wave cognitive behavioural therapies, such as mindfulness-based cognitive therapy, acceptance and commitment therapy, extended behavioural activation, dialectical behaviour therapy, and mindfulness-based stress reduction.

[read the full story...]

Improving antidepressant outcomes: what works for whom and why?

rawpixel-792222-unsplash

Thalia Eley and Gerome Breen explore a new systematic meta-review of predictors of antidepressant treatment outcome in depression, which looks at clinical and demographic variables, but also biomarkers including both genetic and neuroimaging data.

[read the full story...]

Antidepressant withdrawal: reviewing the paper behind the headlines

rawpixel-617402-unsplash

Joseph Hayes and Sameer Jauhar set the record straight on antidepressant withdrawal. They show how the recent review by Davies and Read is seriously flawed and does not accurately portray the data. They conclude that we urgently need clearer evidence on the incidence, severity and duration of any symptoms related to antidepressant withdrawal.

[read the full story...]

Treating depression with physical activity in young people

andrik-langfield-1096044-unsplash

Simon Brett summarises a robust systematic review that looks at the effectiveness of physical activity as a treatment for depression in adolescents and young adults.

[read the full story...]

Behavioural and psychological symptoms of dementia: GPs’ perspective on management

woman-65675_1920

Marie Crabbe presents the findings of a mixed-methods systematic review, which looks at General Practitioners’ knowledge, attitudes and experiences of managing behavioural and psychological symptoms of dementia.

[read the full story...]

A roadmap to advance dementia research and care by 2025

treasure-map-1850653_1280

Clarissa Giebel unfolds and reviews a new roadmap to advance dementia research in prevention, diagnosis, intervention and care by 2025.

[read the full story...]

Medical cannabis for mental illness: current use is not supported by research #MHQT

sharon-mccutcheon-798864-unsplash

As we prepare for our Cannabis #MHQT event on Wed 26 Sep, Luke Sheridan Rains dissects a narrative review that asks: Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

His answer is that current evidence does not support the use of medical cannabis for mental illnesses such as anxiety or depression.

[read the full story...]

The cost of persuasive design: digital media use and ADHD

play-again

Elvira Perez Vallejos and David Daley consider the findings of a recent cohort study in JAMA that looks into the association between digital media use and subsequent symptoms of ADHD in adolescents.

[read the full story...]

Transdiagnostic and disorder-specific anxiety disorder treatments have equivalent treatment effects #TransDX2018

pawel-czerwinski-716699-unsplash

Jill Newby and Peter Norton blog an RCT on the unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders.

[read the full story...]

Social media: good and bad experiences and the impact on depression

robin-worrall-749755-unsplash

Sarah Hetrick publishes her debut blog on a recent US cross-sectional study that looks at the association between positive and negative social media experiences and symptoms of depression.

[read the full story...]